Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

被引:755
作者
Izumi, H [1 ]
Torigoe, T [1 ]
Ishiguchi, H [1 ]
Uramoto, H [1 ]
Yoshida, Y [1 ]
Tanabe, M [1 ]
Ise, T [1 ]
Murakami, T [1 ]
Yoshida, T [1 ]
Nomoto, M [1 ]
Kohno, K [1 ]
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Yahatanishi Ku, Fukuoka 8078555, Japan
关键词
cancer chemotherapy; proton pump; V-ATPase; sodium-proton exchanger; bicarbonate transporter; monocarboxylate transporter; hypoxia; apoptosis;
D O I
10.1016/S0305-7372(03)00106-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
One of the major obstacles to the successful treatment of cancer is the complex biology of solid tumour development. Although regulation of intracellular pH has been shown to be critically important for many cellular functions, pH regulation has not been fully investigated in the field of cancer. It has, however, been shown that cellular pH is crucial for biological functions such as cell proliferation, invasion and metastasis, drug resistance and apoptosis. Hypoxic conditions are often observed during the development of solid tumours and lead to intracellular and extracellular acidosis. Cellular acidosis has been shown to be a trigger in the early phase of apoptosis and leads to activation of endonucleases inducing DNA fragmentation. To avoid intracellular acidification under such conditions, pH regulators are thought to be up-regulated in tumour cells. Four major types of pH regulator have been identified: the proton pump, the sodium-proton exchanger family (NHE), the bicarbonate transporter family (BCT) and the monocarboxylate transporter family (MCT). Here, we describe the structure and function of pH regulators expressed in tumour tissue. Understanding pH regulation in tumour cells may provide new ways of inducing tumour-specific apoptosis, thus aiding cancer chemotherapy. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:541 / 549
页数:9
相关论文
共 62 条
[1]
BARRY MA, 1993, CANCER RES, V53, P2349
[2]
THE CELL BIOLOGY OF MULTIPLE-DRUG RESISTANCE [J].
BECK, WT .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (18) :2879-2887
[3]
TRIFLOCIN, A NOVEL INHIBITOR FOR THE NA-HCO3 SYMPORT IN THE PROXIMAL TUBULE [J].
BELACHGAR, F ;
HULIN, P ;
ANAGNOSTOPOULOS, T ;
PLANELLES, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) :465-470
[4]
Bianchini L, 1997, J BIOL CHEM, V272, P271
[5]
BAFILOMYCINS - A CLASS OF INHIBITORS OF MEMBRANE ATPASES FROM MICROORGANISMS, ANIMAL-CELLS, AND PLANT-CELLS [J].
BOWMAN, EJ ;
SIEBERS, A ;
ALTENDORF, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :7972-7976
[6]
Direct binding of the Na-H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H+ translocation [J].
Denker, SP ;
Huang, DC ;
Orlowski, J ;
Furthmayr, H ;
Barber, DL .
MOLECULAR CELL, 2000, 6 (06) :1425-1436
[7]
INHIBITORY EFFECT OF MODIFIED BAFILOMYCINS AND CONCANAMYCINS ON P-TYPE AND V-TYPE ADENOSINE-TRIPHOSPHATASES [J].
DROSE, S ;
BINDSEIL, KU ;
BOWMAN, EJ ;
SIEBERS, A ;
ZEECK, A ;
ALTENDORF, K .
BIOCHEMISTRY, 1993, 32 (15) :3902-3906
[8]
New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[9]
STRUCTURE OF A 16 KDA INTEGRAL MEMBRANE-PROTEIN THAT HAS IDENTITY TO THE PUTATIVE PROTON CHANNEL OF THE VACUOLAR H+ -ATPASE [J].
FINBOW, ME ;
ELIOPOULOS, EE ;
JACKSON, PJ ;
KEEN, JN ;
MEAGHER, L ;
THOMPSON, P ;
JONES, P ;
FINDLAY, JBC .
PROTEIN ENGINEERING, 1992, 5 (01) :7-15
[10]
STRUCTURE AND FUNCTION OF VACUOLAR CLASS OF ATP-DRIVEN PROTON PUMPS [J].
FORGAC, M .
PHYSIOLOGICAL REVIEWS, 1989, 69 (03) :765-796